Novartis will make an upfront payment of $800-million to acquire all of the outstanding share capital of the company, as well as potential additional milestone payments of up to $700-million, it said in a statement.
Gyroscope Therapeutics has been developing a one-time gene therapy to treat an age-related condition known as geographic atrophy, which causes lesions on the retina and can cause blindness, it said.Novartis said the transaction's closing was still subject to regulatory approvals.
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
MAS Real Estate sells UK investment property for €45.2mProceeds of sale after taxes and mandatory settlements of senior debt facilities will be used for acquisitions
출처: BDliveSA - 🏆 12. / 63 더 많은 것을 읽으십시오 »